Sec Form 4 Filing - Doherty Catherine T. @ QUEST DIAGNOSTICS INC - 2013-09-16

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Doherty Catherine T.
2. Issuer Name and Ticker or Trading Symbol
QUEST DIAGNOSTICS INC [ DGX]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
SVP, Clinical Franchises
(Last) (First) (Middle)
C/O QUEST DIAGNOSTICS INCORPORATED, 3 GIRALDA FARMS
3. Date of Earliest Transaction (MM/DD/YY)
09/16/2013
(Street)
MADISON, NJ07940
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/16/2013 M( 1 ) 15,713 A $ 52.245 88,003 D
Common Stock 09/16/2013 S( 1 ) 15,713 D $ 62 72,290 D
Common Stock 09/17/2013 M( 1 ) 27,621 A $ 52.245 99,911 D
Common Stock 09/17/2013 S( 1 ) 27,621 D $ 62 72,295 ( 3 ) D
Common Stock 3,503 ( 4 ) I 401(k)/SDCP
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $ 52.245 09/16/2013 M( 1 ) 15,713 ( 2 ) 02/12/2014 Common Stock 15,713 $ 0 27,621 D
Stock Options (Right to Buy) $ 52.245 09/17/2013 M( 1 ) 27,621 ( 2 ) 02/12/2014 Common Stock 27,621 $ 0 0 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Doherty Catherine T.
C/O QUEST DIAGNOSTICS INCORPORATED
3 GIRALDA FARMS
MADISON, NJ07940
SVP, Clinical Franchises
Signatures
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Catherine T. Doherty 09/18/2013
Signature of Reporting Person Date
Explanation of Responses:
( 1 )This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on July 30, 2013.
( 2 )The options vested in three annual installments beginning with the first on February 12, 2008, February 12, 2009 and February 12, 2010.
( 3 )The amount includes exempt purchases made under the Company's stock purchase plansince the date of the last filing on Form 4.
( 4 )These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.